These centres have been set to develop the products, technologies in synergy with the requirements of the National Health Mission, Ayushman Bharat and Public Health Programmes of the government for their potential deployment.
The new R&D centre will provide expertise to all of the company’s diverse therapy areas, namely interventional cardiology, peripheral interventions, cardiac rhythm management, endoscopy, neuromodulation, and urology and pelvic health.
With a growing ageing population across the Asia-Pacific region and increased patient demand for access to care at a time and modality of their choice, digital health innovation is no longer an option, but a necessity for health systems if we aspire to emerge stronger from the pandemic.
Though price control is a well-intentioned measure it will have several unintended consequences. The long-term solution to improve access to quality healthcare and medical innovation can’t be brought about by short term policy fixes such as the imposition of price control.
The partnership also includes setting up of a training and education centre on the campus of one of IUIH’s Medicities with GE Healthcare providing course content and skill creation training programmes to the students.
Masuda has been associated with Omron for last three years and prior to coming to India, he was at Shanghai, leading Omron Healthcare business' growth and development for China region from 2012 to 2014.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
